Disc Medicine, Inc.
IRON · Nasdaq · SIC 2834: Pharmaceutical Preparations
Business Summary
1 Item 1A. Risk Factors 46 Item 1B. Unresolved Staff Comments 98 Item 1C. Cybersecurity 98 Item 2. Properties 98 Item 3. Legal Proceedings 99 Item 4. Mine Safety Disclosures 99 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 100 Item 6. Reserved 101 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 102 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 111 Item ...
Next Earnings
Q2 FY2026 — expected 2026-08-10
Key Facts from Earnings Calls
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | IRON | discussed_in_filing Cybersecurity | |
| topic_mention | IRON | discussed_in_filing Cybersecurity | |
| topic_mention | IRON | discussed_in_filing Cybersecurity | |
| topic_mention | IRON | discussed_in_filing Cybersecurity | |
Annual Reports (10-K)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-073602 | EDGAR | 118K words |
| 2025-02-27 | 2024-12-31 | 0000950170-25-028390 | EDGAR | — |
| 2024-03-21 | 2023-12-31 | 0000950170-24-034432 | EDGAR | — |
| 2023-03-31 | 2022-12-31 | 0000950170-23-011139 | EDGAR | — |
| 2022-03-10 | 2021-12-31 | 0000950170-22-003288 | EDGAR | — |
| 2021-03-29 | 2020-12-31 | 0001213900-21-018272 | EDGAR | — |
Quarterly Reports (10-Q)
| Filed | Period | Accession | Source | Full Text |
|---|
| 2025-11-06 | 2025-09-30 | 0001193125-25-268200 | EDGAR | 72K words |
| 2025-08-07 | 2025-06-30 | 0001816736-25-000007 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065069 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0000950170-24-124650 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0000950170-24-093357 | EDGAR | — |
| 2024-05-09 | 2024-03-31 | 0000950170-24-056304 | EDGAR | — |
| 2023-11-09 | 2023-09-30 | 0000950170-23-061572 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0000950170-23-041594 | EDGAR | — |
| 2023-05-15 | 2023-03-31 | 0000950170-23-021963 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0000950170-22-024195 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0000950170-22-016671 | EDGAR | — |
| 2022-05-06 | 2022-03-31 | 0000950170-22-008015 | EDGAR | — |
Recent Current Reports (8-K)
| Filed | Accession | Source | Full Text |
|---|
| 2026-02-27 | 0001193125-26-082855 | EDGAR | 1K words |
| 2026-02-26 | 0001193125-26-073594 | EDGAR | — |
| 2026-02-17 | 0001193125-26-053066 | EDGAR | — |
| 2026-02-13 | 0001193125-26-051504 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009871 | EDGAR | — |
| 2025-12-08 | 0001193125-25-310664 | EDGAR | — |
| 2025-11-06 | 0001193125-25-268196 | EDGAR | — |
| 2025-10-22 | 0001193125-25-245871 | EDGAR | — |
| 2025-10-20 | 0001193125-25-242959 | EDGAR | — |
| 2025-10-17 | 0001193125-25-242026 | EDGAR | — |
134 total filings indexed. 106 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
Sector Peers
Company Identity
| CIK | 0001816736 |
| Ticker | IRON |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
Get More Data
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile
Stock Quote
AI Readiness Report
Origin Provenance
page leaf: 0a1011e523e9b33ee2f6eadfdf09ccf05624fc6c96fbbfcbed2019c6a0adc185
parent: 9f64ce5b2fbc6866b2ca1b4263e0f08c1d9b0097a619b79ec6293bf170758ff8
content hash: 887abdfe5517eb776bae2f3e381c7d42583de88af3c45502c4d393d8d70ca85e
signed: 2026-04-13T04:45:45.150Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf